The Society annually presents an award to an outstanding individual in recognition of their contributions and achievements in the resolution of public environmental concerns. There are no specific criteria, no age limitations, however, international scientific developments in toxicology are of special interest.
THE INTERNATIONAL SOCIETY OF REGULATORY TOXICOLOGY AND PHARMACOLOGY PRESENTS
THE 2019 INTERNATIONAL ACHIEVEMENT AWARD TO:
Dr. Peter Goering, Ph.D., DABT, ATS
Research Toxicologist and Deputy Director
Division of Biology, Chemistry and Materials Science in the
Office of Science and Engineering Laboratories at the
U.S. FDA’s Center for Devices and Radiological Health
December 04, 2019
ISRTP President David Sarvadi’s introduction of Dr. Peter Goering, Ph.D.
We are extremely pleased to announce this year’s recipient of the International Society of Regulatory Toxicology and Pharmacology’s 2019 International Achievement Award, Dr. Peter Goering, PhD, DABT, ATS is the Research Toxicologist and Deputy Director, Division of Biology, Chemistry, and Materials Science in the Office of Science and Engineering Laboratories at the U.S. FDA’s Center for Devices and Radiological Health at the US Food and Drug Administration, Silver Spring, Maryland. Currently, his research interests include nanotechnology/nanotoxicology, elucidating new biomarkers of toxicity, and the toxicology of metals. His nanotechnology research focuses on addressing key challenges associated with the evaluation of nanomaterial characterization and toxicity for improving regulatory decision making and prediction of health risks. He currently serves as CDRH liaison to the American Society for Testing and Materials (ASTM) E56 standards committee on Nanotechnology: Physical, Chemical, and Toxicological Properties. He received his PhD from the Kansas University Medical School and was a postdoctoral fellow at the National Institute of Environmental Health Sciences and joined the FDA Center in 1986. In his more than 30 years of research, Dr. Goering has co-authored over 100 peer-reviewed publications and book chapters, including in the Journal RTP. He is a Diplomate of the American Board of Toxicology (DABT), and a Fellow of Academy of Toxicological Sciences (ATS). He served as President of the Society of Toxicology in 2015-16.
Dr. Goering’s international reputation as an expert is considerable and his scientific accomplishments have had a far-reaching impact and cover a broad range in the areas related to the assessment of potential adverse biological responses associated with medical devices, and development of more efficient, predictive, and sensitive toxicology/biocompatibility test methods.
A prolific author, he has produced over 80 research articles in peer-reviewed journals, including high impact journals such as Nature Biotechnology, ACS Nano, and Toxicological Sciences, made over 120 research presentations at national/international scientific meetings, and has been invited by eminent editors to write 22 book chapters. Under his direction as Lab Leader, the CDRH Laboratory of Toxicology and Biocompatibility has evolved steadily into a unique resource and interconnected program of research, risk assessment, and standards/guidance document development. He organizes and leads a multi-disciplinary team of toxicologists, cell biologists, biomedical engineers, and risk assessment experts, which provides state-of-the-art expertise in toxicology, biocompatibility, and health risk assessment to support the regulatory and public health mission of the FDA and CDRH. With his growing reputation, he has skillfully leveraged resources by attracting experts from academia, government agencies, and the private sector to increase the productivity and value of the research program.
We are most pleased to recognize Dr. Goering for his contributions and achievements promoting sound toxicologic and pharmacologic science as a basis for regulation affecting human safety and health, and the environment.
Past IAA Recipients
- (2018) John Bailey, Ph. D.r
- (2017) Ernest E. McConnell, DVM, MS (Path)
- (2015) James S. Bus, Ph.D., DABT, Fellow ATS
- (2014) Jay I. Goodman, Ph.D.
- (2013) John Fawell, Ph.D.
- (2012) Michael L. Gargas, Ph.D.
- (2011) Michael G. Bird, Ph.D., FRSC
- (2010) Gio Batta Gori, Ph.D.
- (2009) Michael Dourson, Ph.D., DABT, ATS
- (2008) Mildred S. Christian, Ph.D., Fellow, ATS
- (2007) Bernard A. Schwetz, D.V.M., Ph.D<>
- (2006) Elizabeth I. Anderson, Ph.D.
- (2005) Jerome H. Heckman, Esq.
- (2004) Lester M. Crawford, M.D.
- (2003) Curtis D. Klaassen, Ph.D.
- (2002) Donald Hughes, Ph.D.
- (2001) Joseph F. Borzelleca, Ph.D
- (1999) Dr. Alan Rulis, Director, Office of Premarket Approval (OPA)
- (1998) Dr. Roger O. McClellan, President, CIIT, Research Triangle Park, NC
- (1997) Dr. Ian C. Munro, Principal, FRCPath
- (1996) Dr. John Higginson, Retired Professor of Medicine, Georgetown University
- (1995) Robert C. Barnard, Esq., Cleary, Gottlieb, Steen & Hamilton
- (1994) Dr. Philip Abelson, Science Magazine, Washington, DC
- (1993) Dr. C. Jelleff Carr, Managing Editor of RTP, Columbia, MD
- (1991) Dr. John P. Frawley, Health & Environment International, Ltd., Wilmington, DE
- (1990) Dr. John Doull, University of Kansas Medical Center, Kansas City, KS
- (1989) Dr. Frederick Coulston, Coulston Foundation, Alamogordo, NM
- (1988) Dr. Robert A. Neal, Retiring President of CIIT, Research Triangle Park, NC
- (1987) Dr. Gaston A. Vettorazzi, Geneva, Switzerland and Dr. Frank C. Lu, Miami, FL, WHO